移植市場：製品、用途、最終用途別-2025-2030年の世界予測

移植市場は、2023年に286億7,000万米ドルと評価され、2024年には310億9,000万米ドルに達すると予測され、CAGR 8.53％で成長し、2030年には508億6,000万米ドルに達すると予測されています。

移植とは、臓器や組織をある身体から別の身体へ、またはドナー部位から患者の体内の別の場所へ移植する医療処置のことで、損傷したり機能不全に陥ったりした臓器を置き換えて機能を回復させることを目的としています。移植の必要性は、主に臓器不全をもたらす慢性疾患、急性損傷、または先天性欠陥から生じる。調査用途には腎臓、肝臓、心臓、肺、膵臓移植が含まれ、主な最終用途分野は病院、移植センター、研究機関です。市場促進要因としては、慢性疾患の有病率の上昇、移植技術の進歩、ヘルスケア・インフラに対する認識と投資の増加などが挙げられます。再生医療や、組織工学と3Dプリンティングによる生体人工臓器の開発からビジネスチャンスが生まれつつあり、ドナー臓器不足を緩和することで状況を一変させる準備が整っています。

しかし、市場成長は、厳しい規制要件、高コスト、臓器提供や臓器配分をめぐる倫理的懸念などの課題によって制約されています。さらに、免疫学的拒絶反応や長期にわたる合併症は、依然として臨床上の大きな課題となっています。潜在的なビジネスチャンスを生かすため、利害関係者は免疫抑制療法の技術革新に注力し、ドナー意識を高める戦略を立てるべきです。異種移植や幹細胞治療の研究のために、バイオテクノロジー企業とヘルスケアプロバイダーが協力すれば、大きな成長の展望が開けるかもしれないです。さらに、臓器保存や輸送技術のような分野は、移植の遅れを減らし、臓器の生存能力を高めるための有望な手段を提供します。市場の発展に伴い、企業は移植の成功率とレシピエントの生活の質を向上させるために、患者教育と支援プログラムを優先させるべきであり、その結果、競合情勢の中で自社を有利に位置づけることができます。市場力学は、急速な技術進歩やヘルスケア政策の変化によってますますダイナミックになっており、競争力を維持するためには継続的なイノベーションと適応が必要です。

市場力学：急速に進化する移植市場の主要市場インサイトを公開

移植市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の有病率の増加
  • 臓器提供と登録に関する意識の高まり
  • 組織バンクの増加
• 市場抑制要因
  • 臓器不全治療のための臓器提供の不足
• 市場機会
  • 移植手術における技術進歩の高まり
  • 政府や非政府組織による積極的な取り組みの増加
• 市場の課題
  • 移植に関連する倫理的・文化的問題の増大

ポーターの5つの力：移植市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：移植市場における外部からの影響の把握

外部マクロ環境要因は、移植市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析移植市場における競合情勢の把握

移植市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス移植市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、移植市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨移植市場における成功への道筋を描く

移植市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の増加
    • 臓器提供と登録に関する意識の高まり
    • 組織バンクの開発の進展
  • 抑制要因
    • 臓器不全の治療のための臓器提供の不足
  • 機会
    • 移植手術における技術の進歩
    • 政府や非政府組織による積極的な取り組みの増加
  • 課題
    • 移植に関連する倫理的・文化的問題の増大
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 移植市場：製品別

• 免疫抑制薬
• ティッシュ製品

第7章 移植市場：用途別

• オルガン移植
• ティッシュ移植

第8章 移植市場：最終用途別

• 病院
• 移植センター

第9章 南北アメリカの移植市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の移植市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの移植市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Arthrex, Inc.
• Australian Red Cross Lifeblood
• BioLife Solutions Inc.
• Dr. Franz Kohler Chemie GmbH
• LifeCell International Pvt. Ltd.
• Mid-America Transplant
• Novartis AG
• Sanofi S.A.
• Stryker Corporation
• Terumo Corporation
• Teva Pharmaceutical Industries Ltd
• TransMedics, Inc.
• Veloxis Pharmaceuticals
• Zimmer Biomet

LIST OF FIGURES

• FIGURE 1. TRANSPLANTATION MARKET RESEARCH PROCESS
• FIGURE 2. TRANSPLANTATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL TRANSPLANTATION MARKET SIZE, BY END USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL TRANSPLANTATION MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. TRANSPLANTATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. TRANSPLANTATION MARKET DYNAMICS
• TABLE 7. GLOBAL TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL TRANSPLANTATION MARKET SIZE, BY IMMUNOSUPPRESSIVE DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL TRANSPLANTATION MARKET SIZE, BY TISSUE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL TRANSPLANTATION MARKET SIZE, BY ORGAN TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL TRANSPLANTATION MARKET SIZE, BY TISSUE TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL TRANSPLANTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL TRANSPLANTATION MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 26. CANADA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. CANADA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. CANADA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES TRANSPLANTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 43. CHINA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. CHINA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. CHINA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 46. INDIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. INDIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. INDIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 49. INDONESIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 52. JAPAN TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 55. MALAYSIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 58. PHILIPPINES TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 61. SINGAPORE TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 64. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 67. TAIWAN TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 70. THAILAND TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 73. VIETNAM TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 76. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 80. DENMARK TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 83. EGYPT TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 86. FINLAND TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 89. FRANCE TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 92. GERMANY TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 95. ISRAEL TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 98. ITALY TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. ITALY TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ITALY TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 101. NETHERLANDS TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 104. NIGERIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 107. NORWAY TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 110. POLAND TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. POLAND TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. POLAND TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 113. QATAR TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. QATAR TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. QATAR TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 116. RUSSIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 119. SAUDI ARABIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH AFRICA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 125. SPAIN TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 128. SWEDEN TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 131. SWITZERLAND TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 134. TURKEY TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 137. UNITED ARAB EMIRATES TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 143. TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 144. TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023

The Transplantation Market was valued at USD 28.67 billion in 2023, expected to reach USD 31.09 billion in 2024, and is projected to grow at a CAGR of 8.53%, to USD 50.86 billion by 2030.

Transplantation refers to the medical procedure wherein an organ or tissue is transferred from one body to another or from a donor site to another location in the patient's body, aimed at replacing damaged or failing organs to restore functionality. The necessity for transplantation arises primarily from chronic diseases, acute injuries, or congenital defects resulting in organ failure. Applications include kidney, liver, heart, lung, and pancreas transplants, with major end-use areas being hospitals, transplant centers, and research institutes. Significant market drivers include the rising prevalence of chronic diseases, advancements in transplantation technology, and increasing awareness and investments in healthcare infrastructure. Opportunities are emerging from regenerative medicine and the development of bioartificial organs through tissue engineering and 3D printing, which are poised to transform the landscape by alleviating donor organ shortages.

However, market growth is constrained by challenges, such as stringent regulatory requirements, high costs, and ethical concerns around organ donation and allocation. Furthermore, immunological rejection and long-term complications remain significant clinical challenges. To capitalize on potential opportunities, stakeholders should focus on innovation in immunosuppressive therapies and develop strategies to increase donor awareness. Collaboration between biotechnology firms and healthcare providers for research in xenotransplantation and stem cell therapy could unlock significant growth prospects. Moreover, areas like organ preservation and transport technologies offer promising avenues for reducing transplant delays and enhancing organ viability. As the market evolves, companies should prioritize patient education and support programs to improve transplant success rates and quality of life for recipients, thus positioning themselves advantageously within the competitive landscape. The nature of the transplantation market is increasingly dynamic, shaped by fast-paced technological advancements and shifting healthcare policies, necessitating continuous innovation and adaptation to remain competitive.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Transplantation Market

The Transplantation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of chronic diseases
  • Growing awareness about organ donation and registration
  • Rising development of tissue banks
• Market Restraints
  • Shortage of organ donation for treatment of organ failure
• Market Opportunities
  • Rising technological advancement in transplant surgeries
  • Growing active initiatives by government and non-government organizations
• Market Challenges
  • Growing ethical and cultural issues associated with transplantations

Porter's Five Forces: A Strategic Tool for Navigating the Transplantation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Transplantation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Transplantation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Transplantation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Transplantation Market

A detailed market share analysis in the Transplantation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Transplantation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Transplantation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Transplantation Market

A strategic analysis of the Transplantation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Transplantation Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Arthrex, Inc., Australian Red Cross Lifeblood, BioLife Solutions Inc., Dr. Franz Kohler Chemie GmbH, LifeCell International Pvt. Ltd., Mid-America Transplant, Novartis AG, Sanofi S.A., Stryker Corporation, Terumo Corporation, Teva Pharmaceutical Industries Ltd, TransMedics, Inc., Veloxis Pharmaceuticals, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Transplantation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Immunosuppressive Drugs and Tissue Products.
• Based on Application, market is studied across Organ Transplantation and Tissue Transplantation.
• Based on End Use, market is studied across Hospitals and Transplant Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic diseases
    • 5.1.1.2. Growing awareness about organ donation and registration
    • 5.1.1.3. Rising development of tissue banks
  • 5.1.2. Restraints
    • 5.1.2.1. Shortage of organ donation for treatment of organ failure
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising technological advancement in transplant surgeries
    • 5.1.3.2. Growing active initiatives by government and non-government organizations
  • 5.1.4. Challenges
    • 5.1.4.1. Growing ethical and cultural issues associated with transplantations
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Transplantation Market, by Product

• 6.1. Introduction
• 6.2. Immunosuppressive Drugs
• 6.3. Tissue Products

7. Transplantation Market, by Application

• 7.1. Introduction
• 7.2. Organ Transplantation
• 7.3. Tissue Transplantation

8. Transplantation Market, by End Use

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Transplant Centers

9. Americas Transplantation Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Transplantation Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Transplantation Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Arthrex, Inc.
• 3. Australian Red Cross Lifeblood
• 4. BioLife Solutions Inc.
• 5. Dr. Franz Kohler Chemie GmbH
• 6. LifeCell International Pvt. Ltd.
• 7. Mid-America Transplant
• 8. Novartis AG
• 9. Sanofi S.A.
• 10. Stryker Corporation
• 11. Terumo Corporation
• 12. Teva Pharmaceutical Industries Ltd
• 13. TransMedics, Inc.
• 14. Veloxis Pharmaceuticals
• 15. Zimmer Biomet